Business Description
ViroGates AS
ISIN : DK0061030574
Compare
Compare
Traded in other countries / regions
VIRO.Denmark IPO Date
2018-06-26Description
ViroGates AS is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.65 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.57 | |||||
| Debt-to-EBITDA | -0.4 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.4 | |||||
| Beneish M-Score | -2.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.3 | |||||
| 3-Year EBITDA Growth Rate | 8.2 | |||||
| 3-Year EPS without NRI Growth Rate | 9.6 | |||||
| 3-Year FCF Growth Rate | 2.2 | |||||
| 3-Year Book Growth Rate | -30.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.08 | |||||
| 9-Day RSI | 51 | |||||
| 14-Day RSI | 49.15 | |||||
| 6-1 Month Momentum % | -20.42 | |||||
| 12-1 Month Momentum % | -61.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.74 | |||||
| Quick Ratio | 8.6 | |||||
| Cash Ratio | 6.5 | |||||
| Days Inventory | 1002.84 | |||||
| Days Sales Outstanding | 64.06 | |||||
| Days Payable | 193.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.8 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 76.55 | |||||
| Operating Margin % | -193.03 | |||||
| Net Margin % | -190.2 | |||||
| FCF Margin % | -186 | |||||
| ROE % | -116.26 | |||||
| ROA % | -72.04 | |||||
| ROIC % | -178.87 | |||||
| 3-Year ROIIC % | 223.04 | |||||
| ROC (Joel Greenblatt) % | -237.35 | |||||
| ROCE % | -80.11 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.57 | |||||
| PB Ratio | 4.01 | |||||
| Price-to-Tangible-Book | 4.01 | |||||
| EV-to-EBIT | -2.55 | |||||
| EV-to-EBITDA | -2.56 | |||||
| EV-to-Revenue | 4.92 | |||||
| EV-to-FCF | -2.64 | |||||
| Price-to-Net-Current-Asset-Value | 4.08 | |||||
| Price-to-Net-Cash | 18.13 | |||||
| Earnings Yield (Greenblatt) % | -39.22 | |||||
| FCF Yield % | -34.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ViroGates AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 6.905 | ||
| EPS (TTM) (kr) | -2.197 | ||
| Beta | 0.53 | ||
| Volatility % | 78.16 | ||
| 14-Day RSI | 49.15 | ||
| 14-Day ATR (kr) | 0.306979 | ||
| 20-Day SMA (kr) | 5.7575 | ||
| 12-1 Month Momentum % | -61.09 | ||
| 52-Week Range (kr) | 4.98 - 19.508433 | ||
| Shares Outstanding (Mil) | 6.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ViroGates AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ViroGates AS Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
ViroGates AS Frequently Asked Questions
What is ViroGates AS(OCSE:VIRO)'s stock price today?
The current price of OCSE:VIRO is kr5.80. The 52 week high of OCSE:VIRO is kr19.51 and 52 week low is kr4.98.
When is next earnings date of ViroGates AS(OCSE:VIRO)?
The next earnings date of ViroGates AS(OCSE:VIRO) is 2024-11-07.
Does ViroGates AS(OCSE:VIRO) pay dividends? If so, how much?
ViroGates AS(OCSE:VIRO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers